{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:13:19Z","timestamp":1784311999372,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI100879"],"award-info":[{"award-number":["1R01AI100879"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous cell types modulate hematopoiesis through soluble and membrane bound molecules. Whether developing hematopoietic progenitors of a particular lineage modulate the differentiation of other hematopoietic lineages is largely unknown. Here we aimed to investigate the influence of myeloid progenitors on CD34<jats:sup>+<\/jats:sup>cell differentiation into CD56<jats:sup>+<\/jats:sup>innate lymphocytes. Sorted CD34<jats:sup>+<\/jats:sup>cells cultured in the presence of stem cell factor (SCF) and FMS-like tyrosine kinase 3 ligand (FLT3L) give rise to numerous cell types, including progenitors that expressed the prolactin receptor (PRLR). These CD34<jats:sup>+<\/jats:sup>PRLR<jats:sup>+<\/jats:sup>myeloid-lineage progenitors were derived from granulocyte monocyte precursors (GMPs) and could develop into granulocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF)<jats:italic>in vitro<\/jats:italic>. Moreover, CD34<jats:sup>+<\/jats:sup>PRLR<jats:sup>+<\/jats:sup>myeloid progenitors lacked lymphoid developmental potential, but when stimulated with prolactin (PRL) they increased the differentiation of other CD34<jats:sup>+<\/jats:sup>cell populations into the NK lineage in a non-contact dependent manner. Both mRNA and protein analyses show that PRL increased mothers against decapentaplegic homolog 7 (SMAD7) in CD34<jats:sup>+<\/jats:sup>PRLR<jats:sup>+<\/jats:sup>myeloid cells, which reduced the production of transforming growth factor beta 1 (TGF-\u03b21), a cytokine known to inhibit CD56<jats:sup>+<\/jats:sup>cell development. Thus, we uncover an axis whereby CD34<jats:sup>+<\/jats:sup>PRLR<jats:sup>+<\/jats:sup>GMPs inhibit CD56<jats:sup>+<\/jats:sup>lineage development through TGF-\u03b21 production and PRL stimulation leads to SMAD7 activation, repression of TGF-\u03b21, resulting in CD56<jats:sup>+<\/jats:sup>cell development.<\/jats:p>","DOI":"10.1038\/s41598-020-63346-4","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:03:12Z","timestamp":1586858592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage"],"prefix":"10.1038","volume":"10","author":[{"given":"Dejene M.","family":"Tufa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Shank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M.","family":"Yingst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Devon","family":"Trahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonhui","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Verneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"63346_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0167-5699(90)90139-Z","volume":"11","author":"JF Bazan","year":"1990","unstructured":"Bazan, J. F. Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350\u20134 (1990).","journal-title":"Immunol. Today"},{"key":"63346_CR2","doi-asserted-by":"publisher","first-page":"7172","DOI":"10.1073\/pnas.93.14.7172","volume":"93","author":"K Maki","year":"1996","unstructured":"Maki, K. et al. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc. Natl. Acad. Sci. 93, 7172\u20137177 (1996).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"63346_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367\u20131370 (2010).","journal-title":"Nature"},{"key":"63346_CR4","doi-asserted-by":"crossref","unstructured":"Bellone, G. et al. Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis. Blood (1997).","DOI":"10.1182\/blood.V90.1.21.21_21_27"},{"key":"63346_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nri1779","volume":"6","author":"A Wilson","year":"2006","unstructured":"Wilson, A. & Trumpp, A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6, 93\u2013106 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"63346_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/MOH.0b013e3283007db5","volume":"15","author":"CC Zhang","year":"2008","unstructured":"Zhang, C. C. & Lodish, H. F. Cytokines regulating hematopoietic stem cell function. Curr. Opin. Hematol. 15, 307\u2013311 (2008).","journal-title":"Curr. Opin. Hematol."},{"key":"63346_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1084\/jem.20131560","volume":"211","author":"C Daussy","year":"2014","unstructured":"Daussy, C. et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 211, 563\u2013577 (2014).","journal-title":"J. Exp. Med."},{"key":"63346_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate Lymphoid Cells: 10 Years On. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"63346_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mj\u00f6sberg","year":"2011","unstructured":"Mj\u00f6sberg, J. M. et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055\u20131062 (2011).","journal-title":"Nat. Immunol."},{"key":"63346_CR10","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1182\/blood-2010-09-303081","volume":"117","author":"Q Tang","year":"2011","unstructured":"Tang, Q. et al. Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue. Blood 117, 4052\u20134055 (2011).","journal-title":"Blood"},{"key":"63346_CR11","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1182\/blood-2012-07-440099","volume":"121","author":"Y Ahn","year":"2013","unstructured":"Ahn, Y., Blazar, B. R., Miller, J. S. & Verneris, M. R. Lineage relationships of human interleukin-22-producing CD56+ ROR t+ innate lymphoid cells and conventional natural killer cells. Blood 121, 2234\u20132243 (2013).","journal-title":"Blood"},{"key":"63346_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CSN Klose","year":"2014","unstructured":"Klose, C. S. N. et al. Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages. Cell 157, 340\u2013356 (2014).","journal-title":"Cell"},{"key":"63346_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","volume":"41","author":"A Diefenbach","year":"2014","unstructured":"Diefenbach, A., Colonna, M. & Koyasu, S. Development, Differentiation, and Diversity of Innate Lymphoid Cells. Immunity 41, 354\u2013365 (2014).","journal-title":"Immunity"},{"key":"63346_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coi.2015.11.005","volume":"38","author":"K Juelke","year":"2016","unstructured":"Juelke, K. & Romagnani, C. Differentiation of human innate lymphoid cells (ILCs). Curr. Opin. Immunol. 38, 75\u201385 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"63346_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.celrep.2016.09.025","volume":"17","author":"C Seillet","year":"2016","unstructured":"Seillet, C. et al. Deciphering the Innate Lymphoid Cell Transcriptional Program. Cell Rep. 17, 436\u2013447 (2016).","journal-title":"Cell Rep."},{"key":"63346_CR16","doi-asserted-by":"crossref","unstructured":"Tufa, D. M. et al. Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation. Front. Immunol. 10, (2019).","DOI":"10.3389\/fimmu.2019.00510"},{"key":"63346_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","volume":"508","author":"MG Constantinides","year":"2014","unstructured":"Constantinides, M. G., McDonald, B. D., Verhoef, P. A. & Bendelac, A. A committed precursor to innate lymphoid cells. Nature 508, 397\u2013401 (2014).","journal-title":"Nature"},{"key":"63346_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs, A. et al. Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12- and IL-15-Responsive IFN-\u03b3-Producing Cells. Immunity 38, 769\u2013781 (2013).","journal-title":"Immunity"},{"key":"63346_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722\u2013725 (2009).","journal-title":"Nature"},{"key":"63346_CR20","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1182\/blood-2008-06-165225","volume":"113","author":"PS Woll","year":"2009","unstructured":"Woll, P. S. et al. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood 113, 6094\u2013101 (2009).","journal-title":"Blood"},{"key":"63346_CR21","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1182\/blood-2012-07-440099","volume":"121","author":"Y-O Ahn","year":"2013","unstructured":"Ahn, Y.-O., Blazar, B. R., Miller, J. S. & Verneris, M. R. Lineage relationships of human interleukin-22-producing CD56+ ROR\u03b3t+ innate lymphoid cells and conventional natural killer cells. Blood 121, 2234\u201343 (2013).","journal-title":"Blood"},{"key":"63346_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbmt.2011.11.023","volume":"18","author":"SA Dezell","year":"2012","unstructured":"Dezell, S. A. et al. Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods. Biol. Blood Marrow Transplant. 18, 536\u201345 (2012).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"63346_CR23","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1182\/blood-2010-04-281394","volume":"117","author":"B Grzywacz","year":"2011","unstructured":"Grzywacz, B. et al. Natural killer-cell differentiation by myeloid progenitors. Blood 117, 3548\u20133558 (2011).","journal-title":"Blood"},{"key":"63346_CR24","doi-asserted-by":"publisher","unstructured":"Woody, M. A. et al. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp. Hematol. https:\/\/doi.org\/10.1016\/S0301-472X(99)00019-3 (1999).","DOI":"10.1016\/S0301-472X(99)00019-3"},{"key":"63346_CR25","doi-asserted-by":"publisher","unstructured":"Welniak, L. A., Richards, S. M. & Murphy, W. J. Effects of prolactin on hematopoiesis. Lupus https:\/\/doi.org\/10.1191\/096120301717164930 (2001).","DOI":"10.1191\/096120301717164930"},{"key":"63346_CR26","doi-asserted-by":"publisher","unstructured":"Welniak, L. A. et al. Effects of growth hormone and prolactin on hematopoiesis. Leukemia and Lymphoma https:\/\/doi.org\/10.3109\/10428190009059263 (2000).","DOI":"10.3109\/10428190009059263"},{"key":"63346_CR27","doi-asserted-by":"publisher","unstructured":"Recalde, G. et al. Contribution of sex steroids and prolactin to the modulation of T and B cells during autoimmunity. Autoimmunity Reviews https:\/\/doi.org\/10.1016\/j.autrev.2018.03.006 (2018).","DOI":"10.1016\/j.autrev.2018.03.006"},{"key":"63346_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1083-8791(03)00107-1","volume":"9","author":"R Sun","year":"2003","unstructured":"Sun, R. et al. Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice. Biol. Blood Marrow Transplant. 9, 426\u2013434 (2003).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"63346_CR29","doi-asserted-by":"publisher","unstructured":"Majumder, B., Biswas, R. & Chattopadhyay, U. Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.1624 (2002).","DOI":"10.1002\/ijc.1624"},{"key":"63346_CR30","doi-asserted-by":"publisher","unstructured":"Peeva, E. et al. Prolactin modulates the naive B cell repertoire. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI200316530 (2003).","DOI":"10.1172\/JCI200316530"},{"key":"63346_CR31","doi-asserted-by":"publisher","unstructured":"Yang, L., Hu, Y., Li, X., Zhao, J. & Hou, Y. Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells. Int. Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2006.05.001 (2006).","DOI":"10.1016\/j.intimp.2006.05.001"},{"key":"63346_CR32","doi-asserted-by":"publisher","unstructured":"Matera, L. et al. Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology https:\/\/doi.org\/10.1046\/j.1365-2567.2000.00996.x (2000).","DOI":"10.1046\/j.1365-2567.2000.00996.x"},{"key":"63346_CR33","doi-asserted-by":"publisher","unstructured":"Savino, W., Mendes-Da-Cruz, D. A., Lepletier, A. & Dardenne, M. Hormonal control of T-cell development In health and disease. Nature Reviews Endocrinology https:\/\/doi.org\/10.1038\/nrendo.2015.168 (2016).","DOI":"10.1038\/nrendo.2015.168"},{"key":"63346_CR34","doi-asserted-by":"publisher","unstructured":"Matera, L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sciences https:\/\/doi.org\/10.1016\/0024-3205(96)00225-1 (1996).","DOI":"10.1016\/0024-3205(96)00225-1"},{"key":"63346_CR35","doi-asserted-by":"publisher","unstructured":"Gregerson, K. A. Prolactin: Structure, function, and regulation of secretion. In Knobil and Neill\u2019s Physiology of Reproduction https:\/\/doi.org\/10.1016\/B978-012515400-0\/50037-3 (2006).","DOI":"10.1016\/B978-012515400-0\/50037-3"},{"key":"63346_CR36","doi-asserted-by":"publisher","unstructured":"Bole-Feysot, C., Goffin, V., Edery, M., Binart, N. & Kelly, P. A. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews https:\/\/doi.org\/10.1210\/edrv.19.3.0334 (1998).","DOI":"10.1210\/edrv.19.3.0334"},{"key":"63346_CR37","doi-asserted-by":"publisher","unstructured":"Dardenne, M., Kelly, P. A., Bach, J. F. & Savino, W. Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc. Natl. Acad. Sci. https:\/\/doi.org\/10.1073\/pnas.88.21.9700 (2006).","DOI":"10.1073\/pnas.88.21.9700"},{"key":"63346_CR38","doi-asserted-by":"publisher","unstructured":"Clevenge, C. V. & Kline, J. B. Prolactin receptor signal transduction. Lupus https:\/\/doi.org\/10.1191\/096120301717164949 (2001).","DOI":"10.1191\/096120301717164949"},{"key":"63346_CR39","doi-asserted-by":"publisher","unstructured":"Gorvin, C. M. The prolactin receptor: Diverse and emerging roles in pathophysiology. Journal of Clinical and Translational Endocrinology https:\/\/doi.org\/10.1016\/j.jcte.2015.05.001 (2015).","DOI":"10.1016\/j.jcte.2015.05.001"},{"key":"63346_CR40","doi-asserted-by":"publisher","unstructured":"Goffin, V. et al. From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. In Genetic Analysis - Biomolecular Engineering https:\/\/doi.org\/10.1016\/S1050-3862(99)00025-X (1999).","DOI":"10.1016\/S1050-3862(99)00025-X"},{"key":"63346_CR41","doi-asserted-by":"publisher","unstructured":"Sodhi, A. & Tripathi, A. Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: Involvement of p-38 MAP kinase, STAT3 and NF-\u03baB. Cytokine https:\/\/doi.org\/10.1016\/j.cyto.2007.11.007 (2008).","DOI":"10.1016\/j.cyto.2007.11.007"},{"key":"63346_CR42","doi-asserted-by":"publisher","unstructured":"Dardenne, M., De Moraest, M. D. C. L., Kelly, P. A. & Gagnerault, M. C. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology https:\/\/doi.org\/10.1210\/endo.134.5.8156910 (1994).","DOI":"10.1210\/endo.134.5.8156910"},{"key":"63346_CR43","doi-asserted-by":"publisher","unstructured":"Tang, M. W. et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatol. (United Kingdom) https:\/\/doi.org\/10.1093\/rheumatology\/kew316 (2016).","DOI":"10.1093\/rheumatology\/kew316"},{"key":"63346_CR44","doi-asserted-by":"publisher","unstructured":"Xu, D., Lin, L., Lin, X., Huang, Z. & Lei, Z. Immunoregulation of autocrine prolactin: Suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown. Cell. Immunol. https:\/\/doi.org\/10.1016\/j.cellimm.2010.02.018 (2010).","DOI":"10.1016\/j.cellimm.2010.02.018"},{"key":"63346_CR45","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.0407522101","volume":"101","author":"G Ferlazzo","year":"2004","unstructured":"Ferlazzo, G. et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101, 16606\u201311 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63346_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/ni0102-6","volume":"3","author":"A Moretta","year":"2002","unstructured":"Moretta, A., Bottino, C., Mingari, M. C., Biassoni, R. & Moretta, L. What is a natural killer cell? Nat. Immunol. 3, 6\u20138 (2002).","journal-title":"Nat. Immunol."},{"key":"63346_CR47","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1002\/eji.201444676","volume":"44","author":"DM Tufa","year":"2014","unstructured":"Tufa, D. M., Chatterjee, D., Low, H. Z., Schmidt, R. E. & Jacobs, R. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-\u03b1. Eur. J. Immunol. 44, 3717\u201328 (2014).","journal-title":"Eur. J. Immunol."},{"key":"63346_CR48","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/39369","volume":"389","author":"A Nakao","year":"1997","unstructured":"Nakao, A. et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631\u20135 (1997).","journal-title":"Nature"},{"key":"63346_CR49","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","volume":"89","author":"H Hayashi","year":"1997","unstructured":"Hayashi, H. et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165\u201373 (1997).","journal-title":"Cell"},{"key":"63346_CR50","doi-asserted-by":"publisher","first-page":"570 LP","DOI":"10.1158\/0008-5472.CAN-04-4197","volume":"65","author":"J Yu","year":"2005","unstructured":"Yu, J. et al. Human natural killer cell IFN-gamma production: Inhibition by TGF-beta involves SMAD-mediated downregulation of T-BET expression. Cancer Res. 65, 570 LP\u2013570 (2005).","journal-title":"Cancer Res."},{"key":"63346_CR51","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.4049\/jimmunol.1701461","volume":"200","author":"V Zaiatz-Bittencourt","year":"2018","unstructured":"Zaiatz-Bittencourt, V., Finlay, D. K. & Gardiner, C. M. Canonical TGF-\u03b2 Signaling Pathway Represses Human NK Cell Metabolism. J. Immunol. 200, 3934\u20133941 (2018).","journal-title":"J. Immunol."},{"key":"63346_CR52","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/eji.200939910","volume":"40","author":"DSJ Allan","year":"2010","unstructured":"Allan, D. S. J. et al. TGF-\u03b2 affects development and differentiation of human natural killer cell subsets. Eur. J. Immunol. 40, 2289\u20132295 (2010).","journal-title":"Eur. J. Immunol."},{"key":"63346_CR53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/leu.2015.327","volume":"30","author":"RH Rouce","year":"2016","unstructured":"Rouce, R. H. et al. The TGF-\u03b2\/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia 30, 800\u2013811 (2016).","journal-title":"Leukemia"},{"key":"63346_CR54","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1256337","volume":"345","author":"I Fares","year":"2014","unstructured":"Fares, I. et al. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science (80-.). 345, 1509\u20131512 (2014).","journal-title":"Science (80-.)."},{"key":"63346_CR55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nature13228","volume":"510","author":"P van Galen","year":"2014","unstructured":"van Galen, P. et al. The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress. Nature 510, 268\u2013272 (2014).","journal-title":"Nature"},{"key":"63346_CR56","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1172\/JCI38591","volume":"119","author":"K-D Choi","year":"2009","unstructured":"Choi, K.-D., Vodyanik, M. A. & Slukvin, I. I. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell\u2013derived lin\u2013CD34+CD43+CD45+ progenitors. J. Clin. Invest. 119, 2818\u20132829 (2009).","journal-title":"J. Clin. Invest."},{"key":"63346_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20170832","volume":"215","author":"C Harly","year":"2018","unstructured":"Harly, C., Cam, M., Kaye, J. & Bhandoola, A. Development and differentiation of early innate lymphoid progenitors. J. Exp. Med. 215, 249\u2013262 (2018).","journal-title":"J. Exp. Med."},{"key":"63346_CR58","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1182\/blood-2016-07-730440","volume":"129","author":"MG Angelos","year":"2017","unstructured":"Angelos, M. G. et al. Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells. Blood 129, 3428\u20133439 (2017).","journal-title":"Blood"},{"key":"63346_CR59","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1089\/scd.2014.0597","volume":"24","author":"MWH Roeven","year":"2015","unstructured":"Roeven, M. W. H. et al. The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34 + Hematopoietic Stem and Progenitor Cells. Stem Cells Dev. 24, 2886\u20132898 (2015).","journal-title":"Stem Cells Dev."},{"key":"63346_CR60","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.ymthe.2018.06.016","volume":"26","author":"G-Y Lian","year":"2018","unstructured":"Lian, G.-Y. et al. Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3\/Smad7 Signaling. Mol. Ther. 26, 2255\u20132266 (2018).","journal-title":"Mol. Ther."},{"key":"63346_CR61","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","volume":"168","author":"AI Lim","year":"2017","unstructured":"Lim, A. I. et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell 168, 1086\u20131100.e10 (2017).","journal-title":"Cell"},{"key":"63346_CR62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.20092029","volume":"207","author":"N Satoh-Takayama","year":"2010","unstructured":"Satoh-Takayama, N. et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3 \u2212 NKp46 + cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273\u2013280 (2010).","journal-title":"J. Exp. Med."},{"key":"63346_CR63","doi-asserted-by":"publisher","unstructured":"Correale, J., Farez, M. F. & Ysrraelit, M. C. Role of prolactin in B cell regulation in multiple sclerosis. J. Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.02.007 (2014).","DOI":"10.1016\/j.jneuroim.2014.02.007"},{"key":"63346_CR64","doi-asserted-by":"publisher","unstructured":"Dugan, A. L. et al. Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology https:\/\/doi.org\/10.1210\/en.2002-220515 (2002).","DOI":"10.1210\/en.2002-220515"},{"key":"63346_CR65","doi-asserted-by":"publisher","unstructured":"Wu, W. et al. Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation. Gut https:\/\/doi.org\/10.1136\/gutjnl-2013-306083 (2014).","DOI":"10.1136\/gutjnl-2013-306083"},{"key":"63346_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10911-016-9369-0","volume":"22","author":"R Dill","year":"2017","unstructured":"Dill, R. & Walker, A. M. Role of Prolactin in Promotion of Immune Cell Migration into the Mammary Gland. J. Mammary Gland Biol. Neoplasia 22, 13\u201326 (2017).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"63346_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/JME-11-0040","volume":"48","author":"MV Legorreta-Haquet","year":"2012","unstructured":"Legorreta-Haquet, M. V. et al. Prolactin down-regulates CD4+CD25hiCD127low\/\u2212 regulatory T cell function in humans. J. Mol. Endocrinol. 48, 77\u201385 (2012).","journal-title":"J. Mol. Endocrinol."},{"key":"63346_CR68","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1073\/pnas.89.16.7713","volume":"89","author":"P Sabharwal","year":"1992","unstructured":"Sabharwal, P. et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc. Natl. Acad. Sci. USA 89, 7713\u20136 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63346_CR69","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4049\/jimmunol.163.2.576","volume":"163","author":"B Bouchard","year":"1999","unstructured":"Bouchard, B., Ormandy, C. J., Di Santo, J. P. & Kelly, P. A. Immune system development and function in prolactin receptor-deficient mice. J. Immunol. 163, 576\u201382 (1999).","journal-title":"J. Immunol."},{"key":"63346_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2005.01.013","volume":"22","author":"AG Freud","year":"2005","unstructured":"Freud, A. G. et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22, 295\u2013304 (2005).","journal-title":"Immunity"},{"key":"63346_CR71","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.20030323","volume":"198","author":"H Karsunky","year":"2003","unstructured":"Karsunky, H., Merad, M., Cozzio, A., Weissman, I. L. & Manz, M. G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 198, 305\u201313 (2003).","journal-title":"J. Exp. Med."},{"key":"63346_CR72","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1182\/blood-2011-05-353201","volume":"119","author":"S Takagi","year":"2012","unstructured":"Takagi, S. et al. Membrane-bound human SCF\/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 119, 2768\u201377 (2012).","journal-title":"Blood"},{"key":"63346_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/immu.200390003","volume":"33","author":"C Beck","year":"2003","unstructured":"Beck, C., Schreiber, K., Schreiber, H. & Rowley, D. A. c-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum. Eur. J. Immunol. 33, 19\u201328 (2003).","journal-title":"Eur. J. Immunol."},{"key":"63346_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/983698","volume":"2015","author":"E Uribe-Querol","year":"2015","unstructured":"Uribe-Querol, E. & Rosales, C. Neutrophils in Cancer: Two Sides of the Same Coin. J. Immunol. Res. 2015, 1\u201321 (2015).","journal-title":"J. Immunol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63346-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63346-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63346-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T22:35:35Z","timestamp":1696026935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63346-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63346"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63346-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"10 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6335"}}